Is Corticotrophinum [INN-Latin] Safe in Breastfeeding

Question

I am a breastfeeding mother and i want to know if it is safe to use Corticotrophinum [INN-Latin]? Is Corticotrophinum [INN-Latin] safe for nursing mother and child? Does Corticotrophinum [INN-Latin] extracts into breast milk? Does Corticotrophinum [INN-Latin] has any long term or short term side effects on infants? Can Corticotrophinum [INN-Latin] influence milk supply or can Corticotrophinum [INN-Latin] decrease milk supply in lactating mothers?

Corticotrophinum [INN-Latin] lactation summary

Corticotrophinum [INN-Latin] usage has low risk in breastfeeding

DrLact safety Score for Corticotrophinum [INN-Latin] is 3 out of 8 which is considered Low Risk as per our analyses.
A safety Score of 3 indicates that usage of Corticotrophinum [INN-Latin] may cause some minor side effects in breastfed baby.
Our study of different scientific research indicates that Corticotrophinum [INN-Latin] may cause moderate to no side effects in lactating mother.
Most of scientific studies and research papers declaring usage of Corticotrophinum [INN-Latin] low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
While using Corticotrophinum [INN-Latin] We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About Corticotrophinum [INN-Latin] usage in lactation

We are working on a comment for this product.

Answer by DrLact: About Corticotrophinum [INN-Latin] usage in lactation

No information is available on the clinical use of Corticotrophinum [INN-Latin] during breastfeeding. It is unlikely to appear in breastmilk and because it is has a molecular weight of 4540 and a half-life of only 10 to 15 minutes. Absorption by the infant is unlikely because it would probably be destroyed in the infant's gastrointestinal tract. Based on animal data, an increase in breastmilk cortisol levels might be expected after administration of Corticotrophinum [INN-Latin] to a nursing mother.[1] If Corticotrophinum [INN-Latin] is required by the mother, it is not a reason to discontinue breastfeeding.